Clinical Trials Directory

Trials / Conditions / Metastatic Skin Squamous Cell Carcinoma

Metastatic Skin Squamous Cell Carcinoma

9 registered clinical trials studyying Metastatic Skin Squamous Cell Carcinoma — 4 currently recruiting.

StatusTrialSponsorPhase
RecruitingTreatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened I
NCT07042295
National Cancer Institute (NCI)Phase 2
RecruitingImmunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable
NCT05896839
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
RecruitingCemiplimab Before and After Surgery for the Treatment of High Risk Cutaneous Squamous Cell Cancer
NCT04428671
Emory UniversityPhase 1
TerminatedTalimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Car
NCT04163952
Rutgers, The State University of New JerseyPhase 1
Active Not RecruitingTacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or M
NCT03816332
National Cancer Institute (NCI)Phase 1
CompletedCobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
NCT03108131
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingPembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
M.D. Anderson Cancer CenterPhase 2
CompletedErlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma
NCT01198028
M.D. Anderson Cancer CenterPhase 2